4.49k followers • 28 symbols Watchlist by Yahoo Finance
Follow this list to discover and track stocks that were removed from most watchlists by Yahoo Finance users. This list is generated daily and limited to the top 30 stocks that meet the criteria.
Curated by Yahoo Finance
Follow this list to discover and track stocks that were removed from most watchlists by Yahoo Finance users. This list is generated daily and limited to the top 30 stocks that meet the criteria.
Background
Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the Global Financial Markets. We bring these insights to you in the form of watchlists.
Find other winning investment ideas with the Yahoo Finance Screener.
How are these weighted?The stocks in this watchlist are weighted equally.
Watchlist | Change today | 1-month return | 1-year return | Total return |
---|---|---|---|---|
Most removed from watchlists | - | - | - | - |
^GSPC | +0.03% | +0.47% | +26.52% | +5958.69% |
Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
---|
Can 1995 happen again for the big banks? It might be a moonshot scenario for 2025 as the Fed contemplates rate cuts.
Morning Brief Hosts Seana Smith and Brad Smith break down some of Tuesday's trending tickers on the Yahoo Finance platform Mizuho Securities has initiated coverage of Dell Technologies (DELL), giving it an Outperform rating and a price target of $135, citing the growth of its generative AI. Shares of Mobileye Global (MBLY) are trading higher after being excluded from Intel's (INTC) updates about the chip company's "next phase of transformation." This comes after Bloomberg reported that Intel was considering options for its 88% stake in Mobileye. Finally, Bank of America has upgraded Hewlett Packard Enterprise (HPE) stock to a Buy rating and lifted its price target to $24 per share from $21, citing cost-cutting measures and its upcoming acquisition of Juniper Networks (JNPR). For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Melanie Riehl
Pfizer and AstraZeneca Debate: When “the Greater Good” Matters The business pages, and now the mainstream media, have been dominated over the last week with news of Pfizer’s proposed $106bn takeover of AstraZeneca, which would make it the largest ever foreign takeover of a UK company. Now, a number of politicians have become involved and…